Roth Mkm Reiterates Buy Rating for Joint (NASDAQ:JYNT)

Roth Mkm reaffirmed their buy rating on shares of Joint (NASDAQ:JYNT) in a research report released on Friday morning, Benzinga reports. Roth Mkm currently has a $16.00 target price on the stock, up from their previous target price of $13.00.

Separately, TheStreet cut shares of Joint from a c- rating to a d rating in a research note on Thursday, March 7th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Joint currently has a consensus rating of Moderate Buy and a consensus target price of $22.00.

Joint Stock Down 2.0 %

Shares of JYNT opened at $15.79 on Friday. Joint has a one year low of $7.31 and a one year high of $16.35. The stock has a 50-day moving average of $12.17 and a two-hundred day moving average of $10.21.

Joint (NASDAQ:JYNT) last released its quarterly earnings data on Thursday, March 7th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. Joint had a positive return on equity of 3.94% and a negative net margin of 9.24%. The business had revenue of $30.61 million during the quarter, compared to analyst estimates of $29.63 million. On average, equities analysts expect that Joint will post 0.13 earnings per share for the current year.

Hedge Funds Weigh In On Joint

A number of hedge funds have recently bought and sold shares of the business. Hudson Bay Capital Management LP acquired a new position in shares of Joint during the 3rd quarter worth approximately $867,000. WINTON GROUP Ltd acquired a new position in Joint during the third quarter worth $179,000. First Foundation Advisors purchased a new position in Joint during the third quarter valued at $1,336,000. Trexquant Investment LP grew its position in shares of Joint by 15.2% in the third quarter. Trexquant Investment LP now owns 76,589 shares of the company’s stock valued at $689,000 after purchasing an additional 10,122 shares during the period. Finally, Skylands Capital LLC increased its stake in shares of Joint by 20.3% during the fourth quarter. Skylands Capital LLC now owns 603,640 shares of the company’s stock worth $5,801,000 after purchasing an additional 101,850 shares in the last quarter. Hedge funds and other institutional investors own 76.88% of the company’s stock.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.